Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
12.61%Gross Profits to Assets
VS
Market
Sector
Industry
History
$ 14.3Close
$ 8.73 - $ 21.81 52-Week Range
Ticker Information
Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSYNDAX PHARMACEUTICALS INC - Gross Profits to Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SNDX - GPA Historical data
| Date | Total Assets | Gross Profit | Gross Profits to Assets |
|---|---|---|---|
| 6/30/2025 | $ 596.15M | $ 75.19M | 12.61% |
| 3/31/2025 | $ 640.71M | $ 42.01M | 6.56% |
| 12/31/2024 | $ 724.82M | $ 22.85M | 3.15% |
| 9/30/2024 | $ 425.81M | $ 16M | 3.76% |
| 6/30/2024 | $ 476.95M | $ 3.5M | 0.73% |
| 3/31/2024 | $ 543.03M | $ 0 | 0% |
| 12/31/2023 | $ 612.88M | $ 0 | 0% |
| 9/30/2023 | $ 399.22M | $ 0 | 0% |
| 6/30/2023 | $ 431.34M | $ 0 | 0% |
| 3/31/2023 | $ 459.83M | $ 0 | 0% |
Key Performance Insights, Last 5 Years
- SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) GPA stands at 0.85%.
- Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average GPA has been 8.42%.
- The median GPA for SYNDAX PHARMACEUTICALS INC during this period was 0.79%
- SYNDAX PHARMACEUTICALS INC reached its highest GPA over the past 5 years at 35.19%.
- The lowest GPA recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe 0%
SYNDAX PHARMACEUTICALS INC's GPA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GPA Benchmarks
Similar metrics to GPA:
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Asset Turnover - [Calculation] The Asset Turnover ratio measures how effective a company uses its assets to generate revenue. It is calculated as [Revenue] divided by [Assets].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Gross Profit - [Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Definition of Gross Profits to Assets
[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].GP / Assets
(=) GPA GPA for SYNDAX PHARMACEUTICALS INC is calculated as follows: GP [ $ 1.52M ] / Assets [ $ 179.31M ]
(=) GPA [ 0.85% ] SNDX - Gross Profits to Assets, Last 5 years
0%
Minimum
Dec 31, 2022
35.19%
Maximum
Sep 30, 2022
8.42%
Average
0.79%
Median
GPA Benchmark AnalysisMarket
The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
| filtered constituents | 4.13K |
|---|---|
| min | -50.32% |
| max | 83.98% |
| average | 20.16% |
| median | 15.35% |
| std | 19.95% |